Skip to content
Home
LIVE · CORPUS
Dossier

Terns Pharmaceuticals, Inc.

Medium
CompanyUS
The finding

Ownership resolves 65 hops deep toward the ultimate beneficial owner.

/01

At a glance

Dimensions on file
Owners
20
UBO hops
65
/02

Key facts

Risk signal

Terns Pharmaceuticals, Inc. is a Company registered in US resolved across 1 source in the WhiteIntel corporate-ownership graph.

/03

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

Owners / controllers
Holdings / subsidiaries

None in current sources.

Walk the full UBO chain
65 hops lockedStandard

65-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.

Unlock in the full dossier
/04

Directorship network

857 other roles

Where this entity’s officers also hold (or held) positions — the wider network reached through shared people. Roles are registry records, not a claim of control.

Strauss David Eric
Quigley Jill M.
Jung Melita Sun
Kuriakose Emil
Vignola Mark J.
OrbiMed Genesis GP LLC
ORBIMED ADVISORS LLC
GORDON CARL L
OrbiMed Capital GP VII LLC
VIVO CAPITAL FUND VIII, L.P.
VIVO CAPITAL SURPLUS FUND VIII, L.P.
Vivo Opportunity Fund Holdings, L.P.
VIVO CAPITAL VIII, LLC
Vivo Opportunity, LLC
SUNDARAM SENTHIL VEL
Flynn James E
VIVO OPPORTUNITY FUND, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
DEERFIELD PARTNERS, L.P.
DEERFIELD CAPITAL LP

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Terns Pharmaceuticals, Inc.. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Sign in to contribute a tip and earn reputation — it's free.
Loading tips…